![Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1735-4/MediaObjects/13075_2018_1735_Fig2_HTML.png)
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text
![Mortality and causes of death in a Swedish series of systemic sclerosis patients | Annals of the Rheumatic Diseases Mortality and causes of death in a Swedish series of systemic sclerosis patients | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/57/11/682/F1.large.jpg)
Mortality and causes of death in a Swedish series of systemic sclerosis patients | Annals of the Rheumatic Diseases
![Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis - ScienceDirect Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718369304-fx1.jpg)
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis - ScienceDirect
![Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-2140-3/MediaObjects/13075_2020_2140_Fig1_HTML.png)
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text
![Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/c9c7df46-c8c1-469b-83d6-30e2cbd739d6/gr1.jpg)
Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology
![Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era | Annals of the Rheumatic Diseases Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/72/12/1940/F3.large.jpg)
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era | Annals of the Rheumatic Diseases
![The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients - ACR Meeting Abstracts The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2014/08/Paper-36139-abstract-43320-0.png)
The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients - ACR Meeting Abstracts
![Survival and causes of death in 366 Hungarian patients with systemic sclerosis | Annals of the Rheumatic Diseases Survival and causes of death in 366 Hungarian patients with systemic sclerosis | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/67/1/59/F1.large.jpg)
Survival and causes of death in 366 Hungarian patients with systemic sclerosis | Annals of the Rheumatic Diseases
![Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-021-02672-y/MediaObjects/13075_2021_2672_Fig3_HTML.png)
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text
![Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors](https://www.frontiersin.org/files/Articles/433394/fimmu-09-03112-HTML/image_m/fimmu-09-03112-g001.jpg)
Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
![Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-021-02672-y/MediaObjects/13075_2021_2672_Fig2_HTML.png)
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text
![Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients | The Journal of Rheumatology Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/39/10/1971/F2.large.jpg)
Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients | The Journal of Rheumatology
![Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1735-4/MediaObjects/13075_2018_1735_Fig1_HTML.png)
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text
![Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/78/9/1242/F2.large.jpg)